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This study has employed high-resolution NMR spectroscopy of kidney extracts to study alterations in the concentrations of amino acids and
glucose in systemic lupus erythematosus (SLE). We used the well-established mouse model of SLE, MRL/lpr, and their congenic controls, MRL/+.
There was a substantial increase in the tissue concentration of branched-chain amino acids (133%), aromatic amino acids (134%) and
glutathione (122%) in the lupus mice, compared to the controls. Since increased glucose can lead to fibrosis, we used [1-13C] glucose as a tracer
to study its transport into the kidney. Significant increases in the levels of [1-13C] glucose (200% of controls) were observed in the MRL/lpr
mice 15 min after its injection. 13C NMR spectra demonstrated that the 13C-label from [1-13C] glucose was not incorporated into glycolytic and
Krebs cycle related metabolites within 15 min. Furthermore, we found that the expression of the profibrotic cytokine, TGFβ and the regulatory
transcription factor Smad3 are significantly enhanced in MRL/lpr mice compared to the MRL/+ controls. The mRNA and protein expression of
extracellular matrix proteins, fibronectin, laminin, and collagen IV were upregulated in the MRL/lpr mice compared to the controls. All these
changes were significantly reduced by the complement (C) inhibitor, Crry. Our results suggest that C activation causes increased glucose
concentration in the kidney, which can lead to the observed hyperglycemia. This may be one of the important factors that cause increased
extracellular matrix (ECM) deposition through the TGFβ signaling in lupus mice and thereby lead to glomerulosclerosis that translates into
increased kidney disease.
© 2007 Published by Elsevier B.V.Keywords: Autoimmune; MRL/lpr; Glucose; [13C] NMR spectroscopy; Kidney1. Introduction
Systemic lupus erythematosus (SLE) is an autoimmune dis-
order with a wide spectrum of disease features that affect
different organs, including oftentimes the kidney. Manifesta-
tions include autoantibodies, abnormal immune complex
processing, hypocomplementemia, and proliferative glomeru-
lonephritis (GN). The MRL/MpJ-Tnfrsf6lpr (MRL/lpr) and the
congenic MRL/MpJ+/+ (MRL/+) mice are a well-studied lupus
model as they demonstrate several comparable features
observed in human patients [5,6,11–14]. The MRL/lpr mice
have a Fas mutation and display features of autoimmunity and
inflammation [12]. The MRL/+ mice do not have this mutation
and therefore develop disease much later in life and therefore⁎ Corresponding author. Tel.: +1 773 702 4796; fax: +1 773 702 5818.
E-mail address: jalexand@medicine.bsd.uchicago.edu (J.J. Alexander).
0925-4439/$ - see front matter © 2007 Published by Elsevier B.V.
doi:10.1016/j.bbadis.2007.07.002serve as appropriate controls [1,37]. Renal disease in MRL/lpr
mice has similar features to SLE patients, with mesangial
proliferative GN early in disease and diffuse proliferative and
crescentic GN later in the course. Finally, glomerulosclerosis
occurs in the terminal phase of disease that leads to renal failure
and ultimately death.
Complement (C) activation plays a significant role in the
pathogenesis of SLE. Complement cascade proceeds via the
classical, alternative, or mannose-binding lectin pathways
[35,36]. Activation through each of the three pathways
converges at the formation of C3 convertase and leads to a
cleavage of C3. The C3 fragment, C3b attaches covalently to
the antigen–antibody complexes, which is followed by C5
binding and its cleavage to C5a and C5b. The generation of C5b
begins the nonenzymatic assembly of the C5b-9 membrane
attack complex, which can result in cellular death or activation
after membrane insertion [22].
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with the C regulatory protein, Crry, protects kidney cells from
C-mediated injury in vitro and experimental mouse models of
nephrotoxic serum nephritis (NSN) and lupus from renal
disease in vivo [3,27]. Crry is a membrane-bound rodent com-
plement regulator that inhibits the cleavage of C3 into its active
metabolites and blocks both the classic and the alternative
pathway of complement activation [18,21,38].
The complement cascades and glucose pathways are closely
intertwined. Complement was shown to participate in glucose
homeostasis while glucose could influence the expression of
complement regulators [24].
Alteration in glucose levels can cause glomerular mesangial
cell proliferation and increased matrix synthesis [28,39].
Hyperglycemia activates the Smad protein family of transcrip-
tion factors. Smad-2 and -3 activate TGFβ while Smad-6 and
-7 inhibit TGFβ [31,40]. Furthermore, high glucose activates
ERK and PKC-delta leading to enhanced TGFβ signaling
[16]. TGFβ is the key mediator of fibrosis of kidney diseases
in both experimental mouse models and patients. Glomerulo-
sclerosis occurs in this lupus model due to increased
extracellular matrix accumulation which is prevented by C
inhibition [4] but the intracellular signaling remains to be
elucidated.
This study was designed to determine the metabolic turnover
in kidneys of MRL/lpr mice and the MRL/+ controls by nuclear
magnetic resonance (NMR) spectroscopy. 13C NMR allows the
simultaneous calculation of metabolite concentrations and meta-
bolic fluxes and thereby tracks cellular metabolism and inter-
cellular trafficking of substrates in a comprehensive and non-
invasivemanner. Inhibition of C activation prevented alteration in
the downstream intracellular signaling pathways leading to in-
creased ECM synthesis and subsequently organ failure. Our study
suggests a correlation between the concentration of glucose and
metabolites in kidney with ECM deposition and provides
an insight into a possible mechanism of renal injury in lupus
nephritis.
2. Materials and methods
2.1. Mice
To evaluate the role of complement in lupus, MRL/lpr and MRL/lpr mice
generated in the laboratory overexpressing Crry directed by the metallothionein-
I promoter [2,26] were used. MRL/+ mice (Jackson Laboratories, Bar Harbor,
ME) served as appropriate controls. In all animals, the presence of the Crry
transgene was documented by polymerase chain reaction (PCR) and soluble
Crry in sera was identified by enzyme-linked immunosorbent assay (ELISA). At
19 weeks of age the mice were killed for tissue harvest (N10 per group). The
mice were given food and water ad libitum and maintained in 12-h light and dark
cycles. These studies were approved by the University of Chicago Animal Care
and Use Committee.
2.2. Administration of [1-13C] glucose
24-Week-old MRL/lpr and MRL/+ mice were administered [1-13C]-glucose
(200 mg/kg, intraperitoneally; Cambridge Isotope Laboratories, Andover, MA)
and killed exactly 15 min later by decapitation. The blood was taken from the
neck wound for the NMR-spectroscopic analysis of plasma glucose levels and
fractional 13C enrichments ([1-13C]/[12C] glucose). Plasma glucose levels andthe percentage 13C enrichment in glucose were found to be not significantly
different between both groups (data not shown).
2.3. Preparation of kidney extracts
Immediately after sacrifice, blood samples were mixed with 20% perchloric
acid (PCA) and stored at −80 °C. Kidneys were snap frozen in liquid nitrogen,
powdered over liquid nitrogen, and homogenized in 8 ml of a 12% PCA solution
at 0 °C using a motor-driven, polished glass tube Teflon pestle homogenizer. The
homogenate and the blood samples were centrifuged at 40,000×g for 15 min; the
supernatants were placed in an ice bath and neutralized to pH 7.0 with KOH. The
precipitated KClO4 was sedimented by centrifugation (40,000×g for 15 min),
and supernatants were lyophilized.
2.4. NMR spectroscopy
The lyophilized PCA extracts of kidney tissue and blood plasma were
redissolved in 0.6 ml deuterium oxide (D2O) and centrifuged. The pHwas adjusted
to 7.0 with deuterium chloride and NaOD. 1H and 13C NMR spectra were recorded
on Bruker DRX 600 or AMX 360 spectrometers, operating at frequencies of
600MHz or 360MHz for 1H and 150.9MHz or 90.5 MHz for 13C measurements.
1HNMRspectra were recordedwith a 5-mmH,C,N inverse triple resonance probe,
400 accumulations, repetition time of 15 s, spectral width 7183 Hz (DRX 600) or
3623 Hz (AMX 360), data size 16 K, zero filling to 32 K. Chemical shifts were
referenced to lactate at 1.33 ppm. 13C NMR spectra were recorded with on the
AMX 360 spectrometer using a 5-mm Q,N,P probe, 20,000 accumulations,
repetition time of 2.5 s, composite pulse decoupling with WALTZ-16, spectral
width 20,833 Hz, data size 32 K (16K), zero filling to 64 K (32K). Chemical shifts
were referenced to the glucose 1β signal at 96.8 ppm.
2.5. Quantitation of metabolite concentrations
The concentrations (μmol/g tissue) of metabolites were determined from
fully relaxed 1H NMR spectra of kidney extracts, using (trimethylsilyl)
propionic-2,2,3,3,d4-acid as an external standard.
2.6. Kidney water measurement
The percent water content of the kidney was measured by heating the tissue
to 200 °C for 72 h. The percentage of water in the tissue was calculated as ((wet
wt−dry wt)×100/wet wt). Six measurements each were made for lupus and
control mice, and values were arithmetically averaged.
2.7. Immunofluorescence (IF) staining
Kidney (4 μm) sections were fixed using ethanol:ether (1:1) and 95%
ethanol in sequence. After three washes in PBS, the sections were incubated
with antibodies specific to collagen 4, fibronectin, and laminin (Santa Cruz, CA)
followed by fluorescein-conjugated anti-rabbit IgG (ICN Biomedicals, Inc., OH,
USA) and viewed by IF microscopy. No staining was observed in control slides
treated with non-immune rabbit IgG followed by FITC-labeled anti-rabbit
antibody. Sections were observed using a Zeiss microscope at 400×. The slides
were scored in a blinded fashion from 0 to 4 (0 indicating no staining and 4 the
most intense staining).
2.8. Real-time PCR (qRT-PCR)
Frozen kidney (n=5 in each group) was homogenized in Trizol reagent (Life
Technologies BRL, Grand Island, NY), and total RNAwas purified according to
the manufacturer's instructions. cDNAwas generated from RNA using random
hexamers as primers with the SuperScript first-strand synthesis kit (Life
Technologies BRL), according to the manufacturer's instructions. qPCR was
performed using the Prism 7700 reactor and the SybrGreen intercalating dye
method with HotStar DNA polymerase (Applied Biosystems, Foster City, CA).
Each reaction was conducted in a total volume of 50 μl with primers at 200 nM,
1 mM dNTP, 3 mM MgCl2, and 10 μl of sample or standard cDNA. PCR was
carried out with a hot start at 95 °C (5 min) followed by 45 cycles at 95 °C (15 s)/
Table 1
The concentrations of amino acids and glucose were calculated by integration of
the respective signals in 1H NMR spectra of extracts obtained from kidneys of
congenic MRL/+ controls and MRL/lpr mice
Chemical shift (ppm) MRL+/+ MRL/lpr Percent of
MRL
Valine 1.03 (CH3) 5.12±0.61 6.92±0.58 135⁎⁎
Leucine 0.95 (CH3) 2.03±0.14 2.59±0.18 128⁎⁎
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was recorded. Using a standard curve generated from serial dilutions of kidney
cDNA, the ratio of gene expression relative to glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) expression was calculated for each experimental
animal and normalized relative to an average of ratios from the control group.
Products of each reaction yielded a single band when run on agarose gel,
confirming specific amplification. Primers were synthesized by Integrated DNA
Technologies (Coralville, IA), with sequences as follows:Isoleucine 0.92 (CH3) 4.68±0.62 6.08±0.89 130⁎⁎Gene Forward primer, Reverse primer
Phenylalanine 7.31 (C5-H),
7.41 (C6-H)
1.44±0.20 1.89±0.18 131⁎⁎GAPDHTyrosine 6.89 (C6-H), 1.93±0.16 2.64±0.24 137⁎⁎
5′-GGCAAATTCA-
ACGGCACAGT-3′;5′-AGATGGTGA-
TGGGCTTCCC-3′7.19 (C5-H)TGFβGlutathione 2.55 (Glu C4, CH2) 2.30±0.23 2.8±0.38 122⁎
5′-ATACGCCTGA-
GTGGCTGTCT-3′;5′-TGGGACTGA-
TCCCATTGATT-3′Glucose 5.24 (C1α) 7.52±0.96 11.13±1.7 148⁎⁎⁎Laminin 5′-TGGTCGATGC-
CAATAACTCA-3′;5′-CTTGTTTGC-
AGCATCTCTGG-3′Values are given as μmol/g wet weight and represent means±SD for n=5
⁎⁎⁎ ⁎⁎ ⁎Fibronectin
( pb0.001; pb0.01, pb0.05; Student's t-test).5′-TGACAACTGC-
CGTAGACCTG-3′;5′-TCGTCTCTGT-
CAGCTTGCAC-3′Collagen4 5′-ATTCCGAGCC-
AGTCCATTTA-3′;5′-ACCTGAACA-
GCGGCTTATGAT-3′Smad3 5′-GGCTTTGAGG-
CTGTCTACCA-3′;5′-CATCTGGGTG-
AGGACCTTGT-3′Smad7 5′-GCACAAAGT-
GTTCCCTGGTT-3′;5′-CGGCTGTTGA-
AGATGACCTC-3′2.9. Western blotting
Kidneys were immediately frozen in liquid nitrogen, powdered, and then
homogenized on ice in PBS, pH 7.2, containing 10 mM EDTA, 10 mM iodo-
acetamide, 5 mM diisopropylfluorophosphate and 1% NP-40. Nuclei and
cytoplasmic debris were pelleted at 14,000×g. Protein content was estimated in
the supernatant by BCA assay. Equal amounts of solubilized kidney proteins
were dissolved in reducing sample buffer and electrophoresed through a 7.5%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel.
Proteins were electrophoretically transferred to a polyvinylidene difluoride
membrane (Millipore, Bedford, MA, USA). After blocking in 5% non-fat milk
in 0.1 mM NaCl, 0.02 mM Tris (pH 7.2), 0.5% Tween 20 (TBST) overnight, the
membrane was incubated for 2 h in anti-mouse collagen 4, fibronectin, laminin,
TGFβ and actin in TBST. The membrane was then washed in TBST and
incubated in horseradish peroxidase (HRP)-conjugated anti-rabbit IgG (Sigma
Aldrich, St. Louis, MO, USA) at a 1:3000 dilution in TBST for 1.5 h. Thereafter,
the membrane was washed in TBST and developed using enhanced chemi-
luminescence (ECL) reagent (Amersham Pharmacia Biotech, Piscataway, NJ,
USA).
2.10. Statistical analysis
The NMR studies were carried out on two groups: MRL/lpr and MRL/+
mice. Data are expressed as mean±S.D. values obtained from the indicated
number of mice. Data between control and experimental groups were analyzed
using t-test. Differences were considered significant when pb0.05.3. Results
3.1. Changes in the concentrations of amino acids and glucose
in kidneys of MRL/lpr mice
The concentrations of amino acids and glucose were
calculated from 1H NMR spectra (Table 1). Fig. 1 shows seg-
ments of representative 1H NMR spectra of kidney extracts. The
chemical shifts (ppm) were compared with previously published
data. From the high-field region of these spectra (0.8–1.1 ppm)
the concentrations of the three aromatic amino acids valine,
leucine and isoleucine were analyzed. The most abundant aro-matic amino acids phenylalanine and tyrosine were calculated
from their down-field resonances. For the quantification of
glutathione, the proton resonance at C-4 of the glutamyl residue
in glutathione was used. Due to PCA extraction, this resonance
is the sum of the oxidized and reduced form of glutathione.
Glucose concentrations were determined by the C1α resonance.
In MRL/lpr mice, the kidney concentrations of these branched-
chain and aromatic amino acids were increased to 128–137% of
congenic MRL/+ controls (pb0.01). Glutathione increased to
122% of controls (pb0.05). No significant alterations were
observed for other amino acids, such as glutamate, glutamine,
aspartate or alanine (data not shown). Most significant changes
were observed for glucose levels, which increased to 148% of
controls (pb0.001) (Fig. 2).
3.2. Glucose transport into kidney is increased in lupus mice
Increased concentrations of glucose in MRL/lpr kidney suggest
increased transport or decreased utilization. Therefore, their mea-
sured levels may be either from increased uptake or decreased
glucose utilization, or even a combination of the two. We injected
[1-13C] glucose for 15 min. Fig. 1 shows representative 13C NMR
spectra of kidney extracts. In congenic MRL/+ controls, the con-
centrations of [1-13C] glucose (calculated from the 13C satellites in
1H NMR spectra) were very low (7.93±0.52 nmol/g wet weight
(ww)); all other signals in the 13C NMR spectra were due to
naturally abundant 13C in glucose and metabolites (1.1%). How-
ever, in MRL/lpr mice, [1-13C] glucose accumulated 2-fold over
controls to concentrations of 15.93±2.31 nmol/g ww without
incorporation of 13C label into glycolytic- or Krebs cycle-related
metabolites. On the other hand, plasma glucose levels and the
percentage 13C-enrichments in glucose did not change significantly
(data not shown).
3.3. Water content is altered in kidneys of MRL/lpr mice
The water content of kidneys was altered significantly in
MRL/lpr mice as compared to the MRL/+ controls. Total water
content in lupus kidney was increased 6% compared to the
controls (Fig. 3).
Fig. 1. 13C NMR spectra of extracts from the kidneys of 24-week-old MRL/+ control and a MRL/lpr lupus mouse, obtained 15 min after injection of [1-13C]glucose
(200 mg/kg; i.p.). Peak assignments: Cho: choline-containing compounds; Glc: glucose; Glu: glutamate; Lac: lactate; myo-Ins: myo-inositol. ⁎Signals are due to
naturally abundance resonances (1.1% 13C in the metabolites). N=5 in each group.
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the profibrotic signaling molecules TGFβ, protein kinase C-delta,
Smad3 and Smad7 in MRL/lpr mice
High glucose is known to induce the expression of ECM
proteins. Consistent with the glomerulosclerosis observed in
kidneys ofMRL/lprmice, therewas increased expression of ECM
proteins. Since TGFβ induces synthesis of ECM proteins, col-
lagen and fibronectin, in human mesangial cells, we studied the
expression of this profibrotic cytokine and signaling molecules
Smad-3 and -7 in kidneys of lupus mice and the role of C in this
signaling pathway. TGFβ and Smad-3 mRNA expression were
significantly increased in MRL/lpr mice as compared to their
control,MRL/+mice; this increasewas significantly reduced byC
inhibition, in mice with the Crry transgene (Fig. 4). In contrast,
mRNA expression of Smad-7 was significantly reduced in MRL/Fig. 2. Branched-chain amino acids (BCAA), aromatic amino acids (AAA),
glucose and glutathione were increased in MRL/lpr mice above the MRL/+
controls. ⁎pb0.05; ⁎⁎pb0.01. Values are given as % increase above the control.lprmice. Complement inhibition reduced this change, although it
did not reach statistical significance.
3.5. Increased mRNA and protein expression of ECM proteins
in lupus mice
A substantial increase in mRNA expression for fibronectin,
laminin and collagen 4 was observed in MRL/lpr mice com-
pared to the MRL/+ controls, as measured by quantitative RT-
PCR (Fig. 5). This increase was prevented by complement
inhibition in the Crry-tg MRL/lpr mice. Furthermore, this
alteration in ECM mRNA expression was translated into altered
protein expression as observed by both Western blotting and IF
(Fig. 6a and b, respectively).
4. Discussion
SLE is an inflammatory, systemic, autoimmune disease. Lupus
nephritis, with inflammation and scarring within the kidney, is a
major cause of morbidity and mortality [7,8]. Increased glucose
concentrations were observed in SLE patients due to lower glu-
cose disappearance rates which correlated with the inflammatory
indices in those studies [23]. In order to obtain an insight into
alterations of metabolites and glucose in the kidneys of MRL/lpr
mice, we used high-resolution NMR spectroscopy and glucose
labeled with the stable isotope 13C ([1-13C] glucose) [41]. Our
results indicate a stimulated glucose transport in kidney in MRL/
lpr mice compared to their congenic MRL/+ controls.
About 60% of adult patients with lupus nephritis have
renal tubular dysfunction that includes distal renal tubular
acidosis, impaired tubular potassium excretion, hyporenine-
Fig. 3. Kidney water content is increased in MRL/lpr mice: water content was
increased in kidneys of MRL/lpr mice by 6% as compared to MRL/+ controls.
Water content in kidney was calculated as (water content×100) /wet wt. Data
shown are from individual mice. Values represent means±S.D. for n=5 (⁎sig-
nificantly different from controls: ⁎pb0.01).
Fig. 5. Complement inhibition with overexpression of complement receptor 1-
related gene/protein y (Crry)-tg reduces fibronectin, laminin and collagen IV
mRNA overexpression in 24-week-old MRL/MpJ-Tnfrsflpr (MRL/lpr) mouse
kidneys. Shown are quantitative qRT-PCR data in which relative mRNA
expression levels were derived by normalizing individual levels to GAPDH
mRNA expression. Data are presented as mean±S.E.M. There were 5 mice in
each group studied. MRL/lpr saline control compared with MRL/+ normal
control, ⁎pb0.01.
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ability [9,17,19]. Renal gluconeogenesis plays an impor-
tant role in conditions where acidosis occurs such as diabetes
and gradually replaces hepatic gluconeogenesis. Normally,
glucose produced from glutamate provides up to 4% of cir-
culating plasma glucose in vivo [16]. But under these con-
ditions, glucose produced by the kidney can account for a
significantly higher percentage of circulating plasma glucose
[32–34].
Kidneys play an important role in amino acid homeostasis. The
concentrations of both branched-chain and aromatic amino acids
were altered in kidneys of MRL/lpr mice. The alterations in the
amino acid concentrations indicate decreased protein synthesis or
increased protein degradation or both. The kidney is a dynamic
organ, rich in the enzymatic machinery required for amino acid
catabolism and/or oxidation, in particular in the medullary thickFig. 4. (a) The mRNA expression for profibrotic signaling molecules— TGFβ,
Smad3 and Smad7 were assessed by qRT-PCR in renal cortices of MRL/+ (1),
MRL/lpr (2) and MRL/lpr+Crry tg (3) mice and normalized to GAPDH
expression in each sample. Values are given as mean±S.D. for each group.
There are 5 mice in each group. (b) The RT-PCR data were validated at the
protein level by Western blotting. Complement-dependent alterations were
observed in the protein expression of TGFβ, Smad3 and Smad7.ascending limb, which provides energy to sustain active ion
transport [10]. Therefore an alteration in amino acid levels
suggests changes in ion transport and points to the value of future
investigations of amino acid metabolism and ion transport.
Increased glomerular antioxidant enzymes were observed in a
wide variety of glomerular diseases including lupus nephritis,
indicating increased oxidative stress in these settings. In the
present study, glutathione, an important antioxidant, was increased
in lupus mice, which might suggest increased GSH formation as
an adaptive response to oxidative stress in these animals. Cyst(e)
ine is the rate-limiting substrate in de novo synthesis of GSH. In
human vascular smooth muscle cells, the uptake rate of cystine
decreased with increasing glucose concentrations, and supplying
cysteine in the form of lipoic acid resulted in restoration of GSH
[25]. Cystine remained unaltered in the present study, suggesting
that therewas no change in its availability, and the increase inGSH
was a protective response to the existing oxidative stress.
In the present study, ∼6% increase in kidney water content
was observed in the MRL/lpr mice as compared to their controls.
Urea content in the kidneywas also increased about 2-fold (results
not shown). Glucose is an osmolyte, which along with increased
urea, branched-chain and aromatic amino acids could contribute
to the increased water content in the kidneys of the diseasedmice.
Increased concentration of glucose could occur due to in-
creased transport into the kidney or by decreased utilization.
The results obtained using [1-13C] glucose demonstrate a 2-fold
stimulated transport of glucose into the kidney, while this
substrate is not metabolized via glycolytic or Krebs cycle
activity by the kidney within 15 min. Our results suggest that
increased transport could result in increased glucose levels in
kidney, which could be one of the key facilitators inducing
increased ECM protein expression. Given that glucose transport
has been shown to induce fibronectin and collagen expression
[15], this is an attractive explanation for all these findings.
High medium glucose concentration stimulates increased
expression of ECM constituents such as collagen, fibronectin,
and laminin by cells in culture [7]. Glomerulosclerosis that
occurs in lupus includes mesangial expansion and accumulated
ECM. We therefore studied ECM accumulation and the
Fig. 6. (a) Proteins isolated from kidneys of MRl/lpr and MRL/lpr+Crry-tg were subjected to Western blotting technique using antibodies against collagen 4,
fibronectin, laminin. In each lane proteins from a different mouse were loaded. Given here are 3 representative lanes from each group. There were 5 animals in each
group. Values given below each sample are intensity of the band normalized to the corresponding actin intensity analyzed by Image J program. (b) Complement
inhibition with Crry reduces the accumulations of collagens IV, fibronectin and laminin in 24-week-old MRL/lpr mouse glomeruli. Shown are representative
immunofluorescence micrographs from 24-week-old MRL/+ mice (A), MRL/lpr mice treated with saline (B) and MRL/lpr mice with Crry transgene (C), and stained
for collagen IV, fibronectin and laminin. In MRL/lpr mice there are increased deposits of the three ECM proteins collagen 4, fibronectin and laminin. Arrows indicate
staining in a sclerotic mesangial area. ECM protein expression in MRL/lpr mice was reduced by complement inhibition with Crry. Pictures were taken using a Zeiss
microscope at 40× magnification.
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earlier studies, the expression of the profibrotic cytokine,
TGFβ, was significantly induced in MRL/lpr mice [17]. Since
glucose levels were increased in the kidney we studied the
intracellular signaling pathway observed in hyperglycemia.
TGFβ modulates ECM expression in mesangial cells via
interaction with Smads [29,30]. Smad-3 expression (which is an
important signal mediator involved in the fibrotic signal
pathway) was increased and Smad-7 expression was decreased
in MRL/lpr mice strongly suggesting for the first time that the
ECM synthesis in lupus nephritis may follow the same signaling
pathway induced by increased glucose concentration.
Increased glucose alters the constitutive mRNA expression
of C components. C activation is an important facet of the
disease in lupus. Earlier studies have shown that C activation isdefinitely linked to enhanced ECM synthesis and renal fibrosis
[20]. The signaling pathway through which this occurs remains
to be deciphered. Our results in this study demonstrate that the
increased transport of glucose, the subsequent signaling and the
increased ECM accumulation were all reduced by C inhibition
giving us an insight into the possible mechanism for renal
fibrosis in lupus.
In summary, our approach using high-resolution NMR spec-
troscopy provides evidence for the first time that renal glucose
concentration and some aspects of kidney metabolism, e.g.,
amino acid metabolism, are altered in lupus mice and points
towards future research in the direction of ion homeostasis.
Further, our study suggests that C regulated glucose alteration
and the subsequent signaling cascade could cause glomerulo-
sclerosis and ultimately result in organ failure observed in lupus.
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